Mitochondrial Biogenesis: The Resveratrol + Pterostilbene + CoQ10 Case

Sophie Chabloz on July 30, 2026

Mitochondrial Biogenesis: The Resveratrol + Pterostilbene + CoQ10 Case

By Sophie Chabloz | May 2026

NAD+ gets most of the attention in cellular energy conversations, but it's not the only player. Mitochondrial biogenesis, the process by which your cells make new mitochondria, depends on a network of signalling molecules and antioxidants that NAD+ alone doesn't fully address. Resveratrol, pterostilbene, and ubiquinol (CoQ10) are the three compounds with the strongest evidence for supporting this network. This piece sets out what each one does, why they belong together, and how the AVEA Booster combines them with NAD+ precursors to support mitochondrial renewal.

In this article:

  • What mitochondrial biogenesis is and why it matters

  • The PGC-1alpha pathway: the master regulator

  • Resveratrol: the activator with a complicated history

  • Pterostilbene: resveratrol's more bioavailable cousin

  • Ubiquinol (CoQ10): the electron transport workhorse

  • Why these three belong together

  • How AVEA Booster integrates the network

  • Where to go next

What mitochondrial biogenesis is and why it matters

Mitochondria are the energy-producing organelles in your cells. They take the food you eat and the oxygen you breathe and produce ATP, the molecule that powers virtually every cellular process. Each cell has anywhere from a few dozen to several thousand mitochondria, depending on tissue type and energy demand.

Mitochondria are not static. They divide, fuse, get damaged, and get replaced through a process called mitochondrial biogenesis. New mitochondria are continuously generated in cells with high metabolic demand, and damaged mitochondria are degraded through mitophagy.

With age, both processes slow. Mitochondrial biogenesis declines, mitophagy becomes less efficient, and the average mitochondrion in your cells is older and less functional. This is one of the recognised hallmarks of ageing (López-Otín et al., 2023). The cellular consequence is reduced energy output, which shows up as flagging energy and reduced stamina. We cover the broader mitochondrial-ageing picture at https://insights.avea-life.com/guides/longevity-science/mitochondrial-dysfunction/.

The PGC-1alpha pathway: the master regulator

The central regulator of mitochondrial biogenesis is a protein called PGC-1alpha (peroxisome proliferator-activated receptor gamma coactivator 1-alpha). When PGC-1alpha is activated, it turns on the transcription of dozens of genes involved in building new mitochondria, increasing oxidative phosphorylation, and improving fatty acid oxidation.

PGC-1alpha is activated by several signals: a low cellular energy state (a high AMP/ATP ratio detected by AMPK), elevated NAD+ via the SIRT1 pathway, calcium signalling during exercise, and certain plant compounds that mimic these stress responses.

The connection to NAD+: SIRT1 is one of the seven sirtuin proteins, and it deacetylates PGC-1alpha. Deacetylation activates PGC-1alpha. SIRT1 needs NAD+ to function. So adequate NAD+ supports PGC-1alpha activation, which supports mitochondrial biogenesis.

The connection to plant compounds: certain polyphenols (resveratrol, pterostilbene) activate SIRT1 directly or indirectly via AMPK. This produces the same downstream effect on PGC-1alpha and mitochondrial biogenesis as elevating NAD+ alone.

Resveratrol: the activator with a complicated history

Resveratrol is the polyphenol that put sirtuin biology on the map. The 2003 Sinclair lab paper demonstrating SIRT1 activation by resveratrol launched a decade of intense research, much of which produced mixed results.

The current state of the evidence: resveratrol does activate SIRT1 in cells, but the activation is more efficient in the presence of certain substrates than others, which led to early controversy about whether it was a "real" activator. Subsequent work has confirmed that under physiologically relevant conditions, resveratrol supports SIRT1 function. It also activates AMPK, which independently supports mitochondrial biogenesis.

The practical issue with resveratrol is bioavailability. Standard trans-resveratrol is poorly absorbed orally and rapidly metabolised in the liver, so blood levels achieved from typical doses are much lower than the concentrations used in cell studies. The AVEA Booster uses Veri-te trans-resveratrol at 150 mg, formulated for improved bioavailability.

Resveratrol's effects in human trials are real but modest: small improvements in insulin sensitivity, and some effect on markers of vascular function and inflammation. It's a useful supporting compound rather than a magic bullet. We cover the broader picture at https://insights.avea-life.com/longevity/resveratrol-benefits/.

Pterostilbene: resveratrol's more bioavailable cousin

Pterostilbene is structurally similar to resveratrol but with two methoxy groups in place of two hydroxyl groups. This small change has meaningful consequences. Pterostilbene is more lipid-soluble than resveratrol, absorbed more efficiently from the gut, and metabolised more slowly in the liver. The result: blood levels of pterostilbene from a given oral dose can be several times higher than blood levels of resveratrol from the same dose.

Pterostilbene activates SIRT1 and AMPK through similar mechanisms to resveratrol, with the practical advantage of better delivery. It also has more direct effects on cellular antioxidant systems, particularly the Nrf2 pathway.

Pterostilbene is found naturally in blueberries (part of the case for blueberries as a healthy food) and is increasingly available as a stand-alone supplement. The AVEA Booster contains 50 mg of pterostilbene.

The combination of resveratrol and pterostilbene in a single supplement provides complementary access to the SIRT1-AMPK-PGC-1alpha pathway, with two molecules that have somewhat different pharmacokinetic profiles and partially overlapping mechanisms.

Ubiquinol (CoQ10): the electron transport workhorse

While resveratrol and pterostilbene support the regulatory machinery that controls mitochondrial biogenesis, ubiquinol works directly at the operational level. Ubiquinol is the reduced, active form of coenzyme Q10. CoQ10 is a critical component of the electron transport chain, the molecular machinery that generates ATP in mitochondria.

Endogenous CoQ10 production declines with age. Statin medications reduce it further. The result is reduced electron transport efficiency, which in tissues with high energy demand (heart, skeletal muscle, brain) translates to reduced ATP output.

Supplemental CoQ10 raises tissue CoQ10 levels in older adults and in people on statins. The functional-outcomes data are modest but reasonably consistent, and clearest in populations where CoQ10 is depleted (Mortensen et al., 2014).

The form matters. Ubiquinone (the oxidised form) is cheaper but less bioavailable. Ubiquinol (the reduced form) is more expensive but absorbed more efficiently and is closer to the form that actually does the work in your mitochondria. The AVEA Booster uses ubiquinol (the reduced form) at 100 mg per dose. We cover the form question in detail at https://insights.avea-life.com/energy-and-clarity/ubiquinol-benefits/.

Why these three belong together

The case for combining resveratrol, pterostilbene, and ubiquinol rests on biological complementarity.

Resveratrol and pterostilbene support the regulatory pathway (SIRT1-AMPK-PGC-1alpha) that drives mitochondrial biogenesis. They tell your cells to make more mitochondria.

Ubiquinol supports the operational pathway (the electron transport chain) that produces ATP in the mitochondria you already have. It helps your existing mitochondria run better.

NAD+ precursors (NMN) support sirtuin activity and provide the cofactor the entire metabolic network needs to function. They give your cells the currency to operate.

The combination addresses three different layers of the same problem. The AVEA Booster brings these together with NMN-pairing in mind, giving you the regulatory and operational support that NMN alone doesn't provide. The full Booster formulation also includes apigenin (CD38 inhibition, indirectly supporting NAD+), betaine (methylation support), and nicotinamide (B3 nutrition).

How AVEA Booster integrates the network

The Booster contains, per dose: Veri-te trans-resveratrol 150 mg, ubiquinol (CoQ10) 100 mg, pterostilbene 50 mg, apigenin 50 mg, betaine 50 mg, and nicotinamide (B3) 16 mg.

Each compound was chosen for its evidence and specific function. The three highlighted in this article (resveratrol, pterostilbene, ubiquinol) are the mitochondrial biogenesis core. The other three (apigenin, betaine, nicotinamide) support related pathways: CD38 inhibition, methylation, and B3 nutrition.

When taken alongside NMN, the Booster creates a more complete cellular energy support stack than NMN alone. The pairing is deliberate: NMN provides the NAD+ substrate, and the Booster supports the regulatory and operational machinery that NAD+ feeds into.

Where to go next

If you want the broader mitochondrial-ageing picture, "Mitochondrial supplements: what actually supports cellular energy" covers the supplement landscape. For a deeper view of CD38 inhibition, "CD38 inhibition and apigenin: why it matters for NAD+" covers that mechanism specifically. And "NAD+ Decline and How to Restore It" brings everything together.

Related reading from AVEA insights